Usage of cookies

We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our Privacy policy.

Skip to content

Press Release

FLEXISEQTM for Hajj Pilgrims – Pro Bono BioTM Humanitarian Donation Dakar/London 11th June 2012.

Pro Bono Bio is pleased to announce that its Humanitarian Division has made its first charitable donation of products following its commitment to help healthcare in Africa. The donation was made by Pro Bono Bio’s envoy Andrei Garbuz (pictured) to thehead of commission for pilgrimage to holy places of Islam, Mr El Hadji Mansour DIOP in Dakar. The Commissioner General commented “It is with great pleasure and genuine interest that I received the consignment of FLEXISEQ products, kindly made available to the Senegalese pilgrims for the 2012 Hajj. Experience gained from the previous Hajjes shows the point to which osteoarthritis affects the majority of our elderly pilgrims and is the subject of regular consultations with our medical team. This shows the great interest which our pilgrims, and we ourselves, have in such a gesture. Allow me, on behalf of all Senegalese pilgrims and the government of Senegal, to send you our sincere thanks.”

Mr Garbuz stated “This is the first delivery on Pro Bono Bio’s Humanitarian mission following the successful launch of FLEXISEQ in Europe. We hope to be able to do more for African health as sales increase.” Mr Garbuz was then travelling to Kuala Lumpur to launch FLEXISEQ in the Malaysian market, he commented “I hope Malaysian pilgrims will consider FLEXISEQ when they undertake their Hajj in 2012. Hajj is particularly demanding upon the knee joints due to the long hours walking and then kneeling to pray and Flexiseq will help with increased mobility and reduced pain” In London Mr John Mayo CBE said “Our Humanitarian mission is part of what makes Pro Bono Bio different. I am delighted we have made a start on this following the sales of FLEXISEQ in Europe, and wish the pilgrims well for their Hajj.”

About Ascension Healthcare plc

Ascension Healthcare plc is a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for the treatment of haemophilia and osteoarthritis. The Company has three products in clinical development for the treatment of haemophilia A and also a range of internationally marketed products for osteoarthritis sufferers. For more information please visit:

For more information contact

Ascension Healthcare plc
Biresh Roy, Chief Executive Officer

[email protected] / +44 (0)20 7291 5400

Consilium Strategic Communications
(European Media and Investor Enquiries)
Lindsey Neville, Ashley Tapp

Tel: +44 (0)20 3709 5700 / [email protected]